| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
other |
Sensitivity of a Tier I Screening Battery Compared to an in Utero Exposure for Detecting the Estrogen Receptor Agonist 17ß-Estradiol1
DuPont Haskell Laboratory for Toxicology and Industrial Medicine P.O. Box 50, Newark, Delaware 19714
Received November 10, 1997; accepted April 2, 1998
A Tier I screening battery for detecting endocrine active compounds (EACs) has been evaluated for its ability to identify 17ß-estradiol, a pure estrogen receptor agonist. In addition, the responses obtained with the Tier I battery were compared to the responses obtained from F1 generation rats from a 90-day/one-generation reproduction study with 17ß-estradiol in order to characterize the sensitivity of the Tier I battery against the sensitivity of an in utero exposure for detecting EACs. The Tier I battery incorporates two short-term in vivo tests (5-day ovariectomized female battery; 15-day Intact male battery) and an in vitro yeast transactivation system (YTS) for identifying compounds that alter endocrine homeostasis. The Tier I female battery consists of traditional uterotrophic endpoints coupled with biochemical and hormonal endpoints. It is designed to identify compounds that are estrogenic/antiestrogenic or modulate dopamine levels. The Tier I male battery consists of organ weights coupled with microscopic evaluations and a comprehensive hormonal assessment It is designed to identify compounds that have the potential to act as agonists or antagonists to the estrogen, androgen, progesterone, or dopamine receptor; steroid biosynthesis inhibitors (aromatase, 5 
-reductase, and testosterone biosynthesis); or compounds that alter thyroid function. The YTS is designed to identify compounds that bind to steroid hormone receptors (estrogen, androgen, and progesterone) and activate gene transcription. The profile generated for 17ß-estradiol was characteristic of the responses expected with a pure estrogen receptor agonist. In the female battery, responses to 17ß-estradiol included increases in uterine fluid imbibition, uterine weight, estrus conversion, uterine stromal cell proliferation, uterine epithelial cell height, uterine progesterone receptor content, serum prolactin and estradiol levels, and decreases in uterine estrogen receptor content and follicle stimulating hormone and luteinizing hormone levels. In the male battery, responses to 17ß-estradiol included decreases in absolute testis and epididymi-des weights, decreases in relative weights for androgen-dependent tissues (prostate, seminal vesicles, and accessory sex gland unit), hormonal alterations (decreased serum testosterone, dihydrotest-osterone, and LH and increased serum prolactin levels), and microscopic alterations of the testis and epididymides. In the YTS for the estrogen receptor, 17ß-estradiol had an EC50, value of 7.2 x 10–9 M, while DHT and progesterone had little cross-activation. The androgen and progesterone receptor systems were less selective in that 17ß-estradiol activated these systems within 3 orders of magnitude of the primary ligand. In the 90-day/one-generation reproduction study, responses to dietary administration of 17ß-estradiol included alterations in organ weights, developmental landmarks, and hormonal levels. Comparison of the responses obtained with our Tier I battery and an in utero exposure demonstrates that the Tier I screening battery is as sensitive as an in utero exposure for detecting 17ß-estradiol-induced alterations in hormonal homeostasis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. N. Lucas, D. G. Rudmann, K. M. Credille, A. R. Irizarry, A. Peter, and P. W. Snyder The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics Toxicol Pathol, February 1, 2007; 35(2): 199 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Naciff, G. J. Overmann, S. M. Torontali, G. J. Carr, J. P. Tiesman, B. D. Richardson, and G. P. Daston Gene Expression Profile Induced by 17{alpha}-Ethynyl Estradiol in the Prepubertal Female Reproductive System of the Rat Toxicol. Sci., April 1, 2003; 72(2): 314 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. O'Connor, S. R. Frame, and G. S. Ladics Evaluation of a 15-Day Screening Assay Using Intact Male Rats for Identifying Steroid Biosynthesis Inhibitors and Thyroid Modulators Toxicol. Sci., September 1, 2002; 69(1): 79 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. O'Connor, S. R. Frame, and G. S. Ladics Evaluation of a 15-Day Screening Assay Using Intact Male Rats for Identifying Antiandrogens Toxicol. Sci., September 1, 2002; 69(1): 92 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Kim, J.-H. Shin, H. J. Moon, T. S. Kim, I. H. Kang, J.-H. Seok, I. Y. Kim, K. L. Park, and S. Y. Han Evaluation of the 20-Day Pubertal Female Assay in Sprague-Dawley Rats Treated with DES, Tamoxifen, Testosterone, and Flutamide Toxicol. Sci., May 1, 2002; 67(1): 52 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Badger, M. J. J. Ronis, and R. Hakkak Developmental Effects and Health Aspects of Soy Protein Isolate, Casein, and Whey in Male and Female Rats International Journal of Toxicology, May 1, 2001; 20(3): 165 - 174. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Marty, J. W. Crissman, and E. W. Carney Evaluation of the Male Pubertal Assay's Ability to Detect Thyroid Inhibitors and Dopaminergic Agents Toxicol. Sci., March 1, 2001; 60(1): 63 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.O. Goyal, T.D. Braden, M. Mansour, C.S. Williams, A. Kamaleldin, and K.K. Srivastava Diethylstilbestrol-Treated Adult Rats with Altered Epididymal Sperm Numbers and Sperm Motility Parameters, but Without Alterations in Sperm Production and Sperm Morphology Biol Reprod, March 1, 2001; 64(3): 927 - 934. [Abstract] [Full Text]
|
|
|
|
|
|
D. M. Creasy Pathogenesis of Male Reproductive Toxicity Toxicol Pathol, January 1, 2001; 29(1): 64 - 76. [Abstract] [PDF]
|
|
|
|
|
|
J. C. O'Connor, L. G. Davis, S. R. Frame, and J. C. Cook Evaluation of a Tier I Screening Battery for Detecting Endocrine-Active Compounds (EACs) Using the Positive Controls Testosterone, Coumestrol, Progesterone, and RU486 Toxicol. Sci., April 1, 2000; 54(2): 338 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Williams, R. C. Cattley, and S. J. Borghoff Alterations in Endocrine Responses in Male Sprague-Dawley Rats following Oral Administration of Methyl tert-Butyl Ether Toxicol. Sci., March 1, 2000; 54(1): 168 - 176. [Abstract] [Full Text] [PDF]
|
|